F Dx Advisors, Inc. Biogen Inc. Transaction History

F Dx Advisors, Inc.

$362 Million
Q2 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $328,988 - $396,015	1,478 Added 50.65%	4,396 $1.14 Million
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $300,413 - $339,065	1,186 Added 68.48%	2,918 $749,000
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $192,359 - $233,720	-762 Reduced 30.55%	1,732 $480,000
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $74,955 - $103,357	-385 Reduced 13.37%	2,494 $666,000
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $83,830 - $99,689	-447 Reduced 13.44%	2,879 $587,000
Q1 2022 May 03, 2022	BUY	$193.77 - $244.14 $120,912 - $152,343	624 Added 23.09%	3,326 $700,000
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $135,247 - $173,813	-604 Reduced 18.27%	2,702 $648,000
Q3 2021 Oct 08, 2021	SELL	$282.99 - $369.05 $118,855 - $155,001	-420 Reduced 11.27%	3,306 $936,000
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $234,654 - $375,727	-906 Reduced 19.56%	3,726 $1.29 Million
Q1 2021 Apr 14, 2021	BUY	$242.95 - $284.63 $810,481 - $949,525	3,336 Added 257.41%	4,632 $1.3 Million
Q1 2021 Apr 13, 2021	SELL	$242.95 - $284.63 $699,210 - $819,165	-2,878 Reduced 68.95%	1,296 $362,000
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $218,540 - $328,957	925 Added 28.47%	4,174 $1.02 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $131,590 - $151,937	497 Added 18.06%	3,249 $922,000
Q2 2020 Jul 22, 2020	SELL	$258.66 - $342.55 $238,743 - $316,173	-923 Reduced 25.12%	2,752 $736,000
Q1 2020 May 22, 2020	SELL	$268.85 - $341.04 $6.73 Million - $8.53 Million	-25,024 Reduced 87.19%	3,675 $1.16 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $6.65 Million - $8.44 Million	24,734 Added 623.81%	28,699 $666,000
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $82,962 - $114,634	-377 Reduced 8.68%	3,965 $1.18 Million
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $48,054 - $53,897	221 Added 5.36%	4,342 $1.01 Million
Q2 2019 Jul 19, 2019	BUY	$219.29 - $241.72 $51,752 - $57,045	236 Added 6.07%	4,121 $964,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $70,214 - $109,823	-324 Reduced 7.7%	3,885 $918,000
Q4 2018 Apr 29, 2019	SELL	$278.5 - $352.75 $1.12 Million - $1.42 Million	-4,036 Reduced 48.95%	4,209 $1.27 Million
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $387,672 - $491,028	1,392 Added 20.31%	8,245 $2.48 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $640,732 - $837,900	2,183 Added 46.75%	6,853 $2.42 Million
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $354,347 - $422,308	-1,376 Reduced 22.76%	4,670 $1.36 Million
Q1 2018 May 02, 2018	BUY	$260.13 - $367.91 $378,489 - $535,309	1,455 Added 31.69%	6,046 $1.66 Million
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $107,981 - $120,947	-351 Reduced 7.1%	4,591 $1.46 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $226,044 - $265,070	804 Added 19.43%	4,942 $1.55 Million
Q2 2017 Aug 11, 2017	BUY	N/A	4,138	4,138 $1.12 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account